Literature DB >> 20116931

Epidermal SH-protease inhibitor (ACPI, cystatin A) in cancer. A short historical review.

Ari Rinne1.   

Abstract

This review article will re-report the findings from 30 years ago concerning the implications of the acid cystein proteinase inhibitor (ACPI) to the field of cancer research. The original article, published in 1980, has erroneously been omitted from electronic article databases. The findings reported in the original article suggest that some anaplastic lung cancers should be classified as epidermal. In this article we also consider the yet unknown physiological function of ACPI. Furthermore, we will address the simplification of the nomenclature of ACPI and related molecules. Copyright 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20116931     DOI: 10.1016/j.prp.2009.12.005

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  2 in total

1.  Cell cycle- and cancer-associated gene networks activated by Dsg2: evidence of cystatin A deregulation and a potential role in cell-cell adhesion.

Authors:  Abhilasha Gupta; Daniela Nitoiu; Donna Brennan-Crispi; Sankar Addya; Natalia A Riobo; David P Kelsell; Mỹ G Mahoney
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

2.  Gonadotropin Stimulation Has Only a Limited Effect on the Concentration of Follicular Fluid Signalling Proteins: An Antibody Array Analysis.

Authors:  Nick A Bersinger; Markus Eisenhut; Petra Stute; Michael von Wolff
Journal:  Int J Reprod Med       Date:  2021-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.